The 20 Best Paget Disease of the Breast Doctors Near Me in Rosedale, MD

William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL).

Dr. Santa-Maria completed his oncology training at Johns Hopkins, and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. Dr. Santa is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.

Dr. Julie Lange is an assistant professor of surgery, dermatology and oncology at the Johns Hopkins University School of Medicine. Dr. Lange was one of the original members of the Johns Hopkins melanoma group when it was first formed in 1995 and now serves as a clinical co-director of the Melanoma Program. Dr. Lange introduced the sentinel node technique to Johns Hopkins for both melanoma and breast cancer in the 1990s and has extensive experience with this technique. Dr. Lange is a graduate of the Vanderbilt University School of Medicine and completed her general surgery training at Yale-New Haven Hospital. She completed a fellowship in surgical oncology and immunotherapy at the Surgery Branch of the National Cancer Institute as well. Dr. Lange joined the faculty of the Department of Surgery at Johns Hopkins in 1994 and subsequently earned a Sc.M. in clinical investigation at the Johns Hopkins Bloomberg School of Public Health. She has particular interest in melanoma at extremes of age, and in the factors associated with variance in melanoma care. Dr. Lange has published the largest study of melanoma in children, adolescents and young adults. She recognizes that melanoma in the older patient is a growing epidemic and has investigated the socioeconomic, demographic and healthcare factors that influence the treatment of melanoma in older persons. Dr. Lange is a member of the melanoma panel of the National Comprehensive Cancer Network, a group that annually evaluates and revises national treatment guidelines for melanoma. In 2015, she was inducted for her work into the Miller-Coulson Academy of Clinical Excellence, which recognizes outstanding clinicians at Johns Hopkins based on a number of factors, including communication and interpersonal skills, professionalism and humanism, a scholarly approach to clinical practice, and a passion for patient care. Dr. Lange is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Lymphadenectomy.

Dr. Melissa Camp is the lead breast surgeon in the Johns Hopkins Kimmel Cancer Center's Breast Program at Green Spring Station. As the lead breast surgeon, Dr. Camp works closely with experts from medical oncology, radiation oncology, imaging and pathology to deliver comprehensive multidisciplinary breast cancer care to patients in a convenient community setting. Dr. Camp specializes in providing compassionate breast cancer treatment, including nipple-sparing mastectomy and breast conservation surgery, and helping newly-diagnosed patients navigate the decision-making process. She sees patients at The Johns Hopkins Hospital and at Johns Hopkins Health Care & Surgery Center - Green Spring Station. Dr. Camp received her bachelor’s degree in biochemistry/molecular biology summa cum laude from Dartmouth College. She graduated from the Johns Hopkins University School of Medicine and went on to complete residencies in general surgery and preventive medicine and to earn a master's degree in public health from the Johns Hopkins Bloomberg School of Public Health. As a member of the American Society of Breast Surgeons and the Society of Surgical Oncology, Dr. Camp has published several peer-reviewed journal articles and has presented her work at national and international medical meetings. Dr. Camp is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Subareolar Abscess, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy.

Suman Rao is an Oncologist in Rosedale, Maryland. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).

Atsuko Okabe is a Surgical Oncologist in Rosedale, Maryland. Dr. Okabe is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Lump, Intraductal Papilloma, and Lymphadenectomy.

David Euhus is a Surgical Oncologist in Baltimore, Maryland. Dr. Euhus is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Mastectomy, and Lymphadenectomy.

Dr. Civelek is a professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. He serves as the director of the Nuclear Medicine Residency Program. Dr. Civelek earned his medical degree at Istanbul University, Istanbul School of Medicine, and completed his residency at Hacettepe University Medical Center, Ankara. He received a scholarship from the International Atomic Energy Agency when he completed his nuclear medicine residency and fellowship at Johns Hopkins in the Division of Nuclear Medicine. After his period as a postdoctoral fellow, he joined Johns Hopkins Medicine as full-time faculty until 2003. In his early years at Johns Hopkins, Dr. Civelek assisted the clinical and research programs. He later served as director of nuclear cardiology and clinical director, the director of Nuclear Medicine Residency Program, as well as medical director of the Nuclear Medicine Technologist Program. Prior to his return to Johns Hopkins, Dr. Civelek was a professor and director of nuclear medicine and PET at the University of Louisville and a professor and director of nuclear medicine at the Saint Louis University Hospital. Dr. Civelek spent two years in the body MRI and MRI-PET section, Department of Radiology and Imaging Sciences, at National Institutes of Health Clinical Center before serving as the deputy chief in their nuclear medicine section. He is a fellow of the American College of Nuclear Medicine and The American College of Angiology, and is a fellow and founding member of the American Society of Nuclear Cardiology. Dr. Civelek has trained numerous American and international physicians in nuclear medicine, including nuclear cardiology and nuclear oncology. He has a worldwide reputation in nuclear medicine and lectures at medical centers in the U.S. and internationally on nuclear medicine, including nuclear cardiology and nuclear oncology/PET-CT and PET-MRI. Dr. Civelek is committed to the continued progress of nuclear medicine, cardiology and oncology and the development of new tumor-targeting radiopharmaceuticals for imaging and therapy. He supports high quality clinical trials and patient care and safety. To date, Dr. Civelek has published more than 210 peer-reviewed manuscripts and abstracts, and he has participated in and fostered many nuclear oncology research projects. He has served on the editorial boards of several journals. He is a reviewer for multiple scientific journals, including the Journal of Nuclear Medicine, American Journal of Radiology, and Journal of Urology. Dr. Civelek is rated as an Experienced provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Neuroendocrine Tumor, Prostate Cancer, Lung Cancer, and Familial Prostate Cancer.

Jennifer Joh is a General Surgeon in Baltimore, Maryland. Dr. Joh is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Lymphadenectomy, and Mastectomy.

Neil Friedman is a General Surgeon in Baltimore, Maryland. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Breast Cancer, Intraductal Papilloma, Paget Disease of the Breast, Lymphadenectomy, and Mastectomy.

Gauri Bedi is a General Surgeon in Baltimore, Maryland. Dr. Bedi is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Intraductal Papilloma, Paget Disease of the Breast, Lymphadenectomy, and Mastectomy.

Ravin Garg is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Garg is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura.

Roisin Connolly is an Oncologist in Baltimore, Maryland. Dr. Connolly is rated as an Advanced provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Tissue Biopsy.

Dr. Jessica Tao is a medical oncologist specializing in the care of patients with breast cancer. She co-leads the Cancer Center-wide Johns Hopkins Molecular Tumor Board, a multidisciplinary effort to interpret complex genomic information and provide individualized, precision oncology treatment recommendations to patients with all types of cancer. In addition to caring for patients, Dr. Tao maintains an active clinical-translational research program dedicated to developing novel treatments to patients with advanced cancer. Her expertise and research focuses on finding and targeting the molecular changes that drive a person’s tumor and understanding novel mechanisms of response and resistance to targeted therapies. A second major area of her research is development and application of “liquid biopsy” technologies, including circulating tumor DNA, in the early detection and disease monitoring of breast cancer. Dr. Tao is rated as an Advanced provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Syed Nasir is an Oncologist in Towson, Maryland. Dr. Nasir is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast. Dr. Nasir is currently accepting new patients.

Dr. Rima Jean Couzi is a cancer specialist in Towson, Maryland, caring for patients with breast cancer. Dr. Couzi earned her medical degree at the National University of Ireland. She completed residencies at St. Laurence's Hospital/Beaumont Hospitals and Galway Regional in Dublin, as well as Franklin Square Hospital in Baltimore. She performed a fellowship in medical oncology at St. Vincent's Hospital and St. James's Hospital in Dublin, and an additional fellowship in medical oncology at Johns Hopkins Oncology Center in Baltimore. She also earned a master’s degree in clinical epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Couzi joined the Johns Hopkins faculty in 2004. Dr. Couzi is a member of the American Society of Clinical Oncology and the Royal College of Physicians in Ireland. Selected Publications Antonarakis ES, Fradin JM, Petronis JD, Couzi RJ. “Not What It Seems.” Am J Med. 2007;120:408-411 Holdhoff M, Wung PK, Petronis J, Couzi R. “Persistent PET-positive liver lesions after successful chemotherapy in a patient with mediastinal seminoma.” J. Clin Oncol. 2007;25:2482-4. Li S, Couzi RJ, Thomas GH, Friedman AD, Borowitz MJ. “A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy.” Cancer Genet Cytogenet. 2001; 125:74-7. Schultz MJ, Tabb RD, Eagan JW, Citron JR, Couzi RJ. “Treating a male breast cancer patient with moderately differentiated, infiltrating ductal cancer of the breast.” Journal of Multidisciplinary Cancer Care. 2009 September – October. Siegelbaum MH, Citron JR, Eagan JW, Couzi RJ. “Treating a patient with Unfavorable-risk prostate cancer.” Journal of Multidisciplinary Cancer Care. 2009; July – August. Dr. Couzi is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer.

Charles Boice is an Oncologist in Baltimore, Maryland. Dr. Boice is rated as an Advanced provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Malignant Mixed Mullerian Tumor, Hernia Surgery, and Oophorectomy.

Leisha Emens is an Oncologist in Baltimore, Maryland. Dr. Emens is rated as an Experienced provider by MediFind in the treatment of Paget Disease of the Breast. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Ovarian Cancer.

Maen Farha is a General Surgeon in Baltimore, Maryland. Dr. Farha has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Paget Disease of the Breast. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Colostomy.